查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654685

全球靜脈留置針市場 - 2025 至 2033 年

Global IV Cannula Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球靜脈留置針市場規模達到 4,590 萬美元，預計到 2033 年將達到 7,470 萬美元，2025-2033 年預測期間的複合年成長率為 5.6%。

靜脈插管（IV 插管）是一種醫療設備，用於進入患者的靜脈注射液體、藥物或抽血。它是一種細小而柔軟的管子，通常透過針頭插入靜脈，然後拔出針頭，留下套管以便繼續進行操作。它專為短期至中期使用而設計，必須小心處理以防止併發症。

由於慢性病發病率不斷上升、外科手術增多、醫療保健基礎設施的進步以及家庭醫療保健服務的不斷擴大等多種因素，靜脈留置針市場正在穩步成長。由於許多患者現在在家中接受抗生素、化療或補液療法等治療，因此向家庭醫療保健和門診護理的轉變增加了對靜脈插管的需求。這導致對易於使用、安全且可靠的靜脈輸液系統的需求增加。例如，美國臨床腫瘤學會 (ASCO) 報告稱，美國每年診斷出超過 180 萬例新癌症病例，其中許多患者需要在家中進行靜脈化療輸液，這導致家庭醫療保健對靜脈插管的需求不斷增加。

市場動態：

促進因素與約束因素

外科手術數量不斷增加

外科手術數量的增加極大地推動了靜脈插管市場的成長，預計將在預測期內推動市場的發展。它們的主要用途是在手術期間提供液體管理、藥物輸送、麻醉和輸血。隨著醫療技術的進步，全球選擇性手術和緊急手術的數量增加。這些程序需要透過靜脈注射來實現各種目的，例如麻醉、液體管理和藥物管理。

例如，根據美國國立衛生研究院（NIH）的數據，全球每年進行超過 3.1 億例大型手術，其中美國進行約 4,000 萬至 5,000 萬例手術，歐洲進行 2,000 萬例手術。外科手術數量的不斷增加凸顯了醫院和外科中心對靜脈插管的持續需求。

心臟外科手術、腫瘤外科手術、骨科手術、整形外科手術和神經外科手術等外科專業的日益增多，需要專門的靜脈輸液通路設備，包括具有安全系統或用於精細手術的小型儀表等先進功能的設備。例如，根據國際美容整形外科學會（ISAPS）的數據，外科手術數量增加了5.5%，整形外科醫生進行了超過1580萬例手術，並進行了1910萬例非手術手術。過去四年，整體成長率為40%。整形手術的興起增加了靜脈插管的需求。

感染和併發症的風險

使用靜脈插管相關的感染和併發症風險是阻礙靜脈插管市場成長的重要因素。感染和其他併發症會導致嚴重的健康問題、延長住院時間並增加醫療費用，從而降低患者滿意度並削弱靜脈注射療法的有效性。

使用靜脈插管的主要問題之一是院內感染 (HAI) 的風險，尤其是血流感染 (BSI) 和局部感染。這些感染通常是由於插入不當、缺乏衛生或長時間使用套管引起的，從而導致靜脈炎或敗血症等併發症。

例如，根據醫療保健研究和品質機構的數據，中心靜脈導管相關血流感染 (CLABSI) 是最常見的 HAI 類型之一，美國每年報告約 28,000 例。

由於套管針引起的刺激而引起的靜脈發炎會導致疼痛、腫脹，有時還會導致感染。滲透，即靜脈輸液洩漏到周圍組織而不是進入血液，是另一個嚴重的併發症。醫護人員在插入、操作或拔出靜脈插管時有遭受針刺傷的風險，尤其是在高風險環境中。這些傷害可能導致接觸愛滋病毒、B型肝炎和C型肝炎等血源性病原體。

例如，根據美國疾病管制與預防中心 (CDC) 的數據，美國醫院每年約有 385,000 起針刺傷和其他銳器相關傷害，其中許多涉及靜脈插管。這引發了人們對醫護人員和病人安全的擔憂，影響了對具有內置保護功能的更安全的靜脈插管的需求。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 按規格大小截取的片段
  • 材料片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 外科手術數量不斷增加
    • 限制
      • 感染和併發症的風險
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：靜脈留置針市場（依產品類型）

  • 周邊靜脈插管
  • 中心靜脈插管
  • 引流管

第 6 章：靜脈留置針市場（依規格尺寸）

  • 14G
  • 16G
  • 17G
  • 18G
  • 20G
  • 22克
  • 24G
  • 26克

第 7 章：靜脈留置針市場（依材料）

  • 聚氨酯
  • 特氟龍（聚四氟乙烯 (PTFE)）
  • 矽酮
  • PVC（聚氯乙烯）
  • 其他

第 8 章：靜脈留置針市場（依應用）

  • 輸血
  • 藥品管理局
  • 外科手術
  • 診斷程序
  • 其他

第 9 章：靜脈留置針市場（依最終用戶分類）

  • 醫院
  • 專科診所
  • 家庭護理設置
  • 其他

第 10 章：靜脈注射插管市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 12 章：公司簡介

  • Becton, Dickinson and Company
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
    • SWOT 分析
  • Nipro Corporation
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Medtronic plc
  • Cruzine
  • MRK Healthcare Pvt. Ltd.
  • Bio Med Healthcare Products Pvt Ltd
  • AdvaCare Pharma
  • iLife Medical Devices Pvt Ltd
  • Neotec Medical

第 13 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 14 章：附錄

簡介目錄
Product Code: MDP9129

The global IV cannula market reached US$ 45.9 million in 2024 and is expected to reach US$ 74.7 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

An IV cannula, also known as an intravenous cannula, is a medical device used to provide access to a patient's vein for the purpose of administering fluids, medications or drawing blood. It is a small, flexible tube typically inserted into the vein through a needle, which is then removed, leaving the cannula in place to allow ongoing access. It is designed for short- to medium-term use and must be handled with care to prevent complications.

The IV cannula market is growing steadily due to various factors such as the increasing prevalence of chronic diseases, rising surgical procedures, advancements in healthcare infrastructure and expanding home healthcare services. The shift towards home healthcare and outpatient care has increased the demand for IV cannulas, as many patients now receive treatments like antibiotics, chemotherapy, or hydration therapy at home. This has led to a rise in demand for easy-to-use, safe, and reliable IV access systems. For instance, the American Society of Clinical Oncology (ASCO) reports that over 1.8 million new cancer cases are diagnosed annually in the U.S., and many of these patients will require home-based IV chemotherapy infusions, contributing to the rising demand for IV cannulas in home healthcare.

Market Dynamics: Drivers & Restraints

Rising number of surgical procedures

The rising number of surgical procedures is significantly driving the growth of the IV cannula market and is expected to drive the market over the forecast period. Their primary use is for providing fluid administration, medication delivery, anesthesia, and blood transfusion during surgeries. With advancements in medical technology, the global number of both elective and emergency surgeries has increased. These procedures require IV access for various purposes such as anesthesia, fluid management, and medication administration.

For instance, according to the National Institute of Health (NIH), globally, over 310 million major surgeries are performed every year, in this, around 40 to 50 million surgeries are performed in USA and 20 million surgeries are performed in Europe. This rising number of surgical procedures highlights a continuous demand for IV cannulas in hospitals and surgical centers.

The rise in the variety of surgical specialties such as cardiac surgeries, oncological surgeries, orthopedic surgeries, plastic surgeries and neurosurgeries necessitates specialized IV access devices, including those with advanced features like safety systems or small gauges for delicate procedures. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons and 19.1 non-surgical procedures. Over the last four years, the overall increase is 40%. This rising plastic surgeries boosts the demand for IV cannulas.

Risk of infections and complications

The risk of infections and complications associated with the use of IV cannulas is a significant factor hampering the growth of the IV cannula market. Infections and other complications can lead to severe health issues, prolonged hospital stays, and increased medical costs, which can reduce patient satisfaction and undermine the effectiveness of IV therapies.

One of the major concerns with IV cannula use is the risk of hospital-acquired infections (HAIs), particularly bloodstream infections (BSIs) and local site infections. These infections are typically caused by improper insertion, lack of hygiene or prolonged use of the cannula, leading to complications such as phlebitis or sepsis.

For instance, according to Agency for Healthcare Research and Quality, central-line-associated bloodstream infections (CLABSIs) are among the most common types of HAIs, with approximately 28,000 cases reported annually in the U.S. These infections can result from the use of intravenous catheters, contributing to the hesitancy in using IV cannulas and slowing market growth.

Inflammation of the vein due to irritation caused by the cannula can lead to pain, swelling, and sometimes infection. Infiltration, where the IV fluid leaks into the surrounding tissue instead of entering the bloodstream, is another significant complication. Healthcare workers are at risk of needle-stick injuries when inserting, manipulating, or removing IV cannulas, especially in high-risk environments. These injuries can lead to exposure to bloodborne pathogens such as HIV, Hepatitis B and Hepatitis C.

For instance, according to Centers for Disease Control and Prevention (CDC), approximately 385,000 needle-stick injuries and other sharps-related injuries occur annually in U.S. hospitals, many involving IV cannulas. This raises concerns about the safety of healthcare workers and patients, influencing the demand for safer IV cannulas with built-in protective features.

Segment Analysis

The global IV cannula market is segmented based on product type, gauge size, material, application, end-user and region.

Product Type:

The peripheral IV cannula segment is expected to dominate the IV cannula market share

Peripheral IV cannulas are primarily used for fluid infusion, medication administration, blood transfusions and anesthesia in patients requiring short-term intravenous access. They are particularly common in emergency departments, pediatric care and surgical units. For instance, the American Society of Anesthesiologists (ASA) reports that over 40 to 50 million surgeries are performed annually in the U.S., with peripheral IV cannulas being used in a majority of these procedures for anesthesia and fluid administration.

Peripheral IV cannulas are typically used for short-term intravenous access (generally up to 72 hours) and can be quickly inserted into peripheral veins, such as those in the arm, hand, or forearm. The ease of insertion makes them ideal for emergency situations and routine clinical procedures. According to a study in the Journal of Infusion Nursing, peripheral IV cannulas are used in approximately 75-80% of all hospital admissions for intravenous therapy, largely due to their simplicity, speed, and effectiveness.

Geographical Analysis

North America is expected to hold a significant position in the IV cannula market share

The high prevalence of surgeries in North America, driven by the aging population and the widespread use of medical technologies, directly boosts the demand for IV cannulas. These procedures require intravenous access for medications, fluids, and anesthesia. The National Institute of Health (NIH) reports that more than 40 million surgeries are performed annually in the U.S., most of which involve the use of IV cannulas for intravenous access during procedures.

In North America, there is a growing focus on patient safety and the prevention of healthcare-associated infections (HAIs), which drives demand for safer IV cannulas. This includes the adoption of safety features in IV cannulas, such as shielded needles, antimicrobial coatings and advanced insertion technology. The demand for safer IV cannulas in North America is accelerating due to an increased focus on preventing needle-stick injuries and hospital-acquired infections (HAIs).

Asia-Pacific is growing at the fastest pace in the IV cannula market

Several countries in the APAC region, such as India, China, and Southeast Asia, are experiencing rapid growth in their healthcare infrastructure. Governments and private sectors are investing in medical facilities, hospitals, and clinics to meet the needs of a growing and aging population, which directly contributes to the demand for medical devices, including IV cannulas.

For instance, the Indian government has introduced initiatives like the Ayushman Bharat program, which aims to provide healthcare access to over 500 million people. This program has led to increased healthcare investments, directly boosting demand for medical devices such as IV cannulas.

The rise in medical tourism in countries such as India, Thailand, and Singapore contributing to the demand for advanced medical devices like IV cannulas. Medical tourists often seek affordable and high-quality medical treatments, including surgeries, which require intravenous therapies, driving the market for IV cannulas. For instance, India is one of the world's top destinations for medical tourism, with over 5 million medical tourists visiting annually for treatments like cardiac surgery, orthopedic surgeries, and cosmetic surgeries, all of which require intravenous access.

Competitive Landscape

The major global players in the IV cannula market include Becton, Dickinson and Company, Nipro Corporation, Romsons Scientific & Surgical Pvt. Ltd., Medtronic plc, Cruzine, MRK Healthcare Pvt. Ltd., Bio Med Healthcare Products Pvt Ltd, AdvaCare Pharma, iLife Medical Devices Pvt Ltd, Neotec Medical and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global IV cannula market report delivers a detailed analysis with 78 key tables, more than 83 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Gauge Size
  • 2.5. Snippet by Material
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Number of Surgical Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Infections and Complications
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. IV Cannula Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Peripheral IV Cannula*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Central IV Cannula
  • 5.4. Draining Cannulas

6. IV Cannula Market, By Gauge Size

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 6.1.2. Market Attractiveness Index, By Gauge Size
  • 6.2. 14G*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 16G
  • 6.4. 17G
  • 6.5. 18G
  • 6.6. 20G
  • 6.7. 22G
  • 6.8. 24G
  • 6.9. 26G

7. IV Cannula Market, By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. Polyurethane*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Teflon (Polytetrafluoroethylene (PTFE))
  • 7.4. Silicone
  • 7.5. PVC (Polyvinyl Chloride)
  • 7.6. Others

8. IV Cannula Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Blood Transfusion*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Drug Administration
  • 8.4. Surgical Procedures
  • 8.5. Diagnostic Procedures
  • 8.6. Others

9. IV Cannula Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Homecare Settings
  • 9.5. Others

10. IV Cannula Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Becton, Dickinson and Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Nipro Corporation
  • 12.3. Romsons Scientific & Surgical Pvt. Ltd.
  • 12.4. Medtronic plc
  • 12.5. Cruzine
  • 12.6. MRK Healthcare Pvt. Ltd.
  • 12.7. Bio Med Healthcare Products Pvt Ltd
  • 12.8. AdvaCare Pharma
  • 12.9. iLife Medical Devices Pvt Ltd
  • 12.10. Neotec Medical

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us